Atlas Trials

Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis

Clinical trial NCT05121402 · WITHDRAWN

Trial details

NCT number
NCT05121402
Sponsor
TLL Pharmaceutical, LLC
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2022-12-30
Primary completion
2023-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.